Ian Creese

Rutgers University, New Brunswick, New Brunswick, NJ, United States 
"Ian Creese"
Mean distance: 14.03 (cluster 11)
Cross-listing: PsychTree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ouagazzal AM, Creese I. (2000) Intra-accumbens infusion of D(3) receptor agonists reduces spontaneous and dopamine-induced locomotion. Pharmacology, Biochemistry, and Behavior. 67: 637-45
Creese I, Tepper JM. (1998) Antisense knockdown of brain dopamine receptors. Advances in Pharmacology (San Diego, Calif.). 42: 517-20
Dong ZJ, Chen LJ, Jin GZ, et al. (1997) GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum. Biochemical Pharmacology. 54: 227-32
Tarazi FI, Florijn WJ, Creese I. (1997) Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment. Neuroscience. 78: 985-96
Tepper JM, Sun BC, Martin LP, et al. (1997) Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 2519-30
Florijn WJ, Tarazi FI, Creese I. (1997) Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. The Journal of Pharmacology and Experimental Therapeutics. 280: 561-9
Florijn WJ, Tarazi FI, Creese I. (1997) Chapter 4 Dopamine receptors Principles of Medical Biology. 8: 73-94
Creese I, Burt DR, Snyder SH. (1996) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. The Journal of Neuropsychiatry and Clinical Neurosciences. 8: 223-6
Tarazi FI, Florijn WJ, Creese I. (1996) Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology. 128: 371-9
Creese I. (1996) Antisense “knockout” of brain dopamine receptors: Potential antipsychotics? European Neuropsychopharmacology. 6: S4-27
See more...